N.E.W. Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.38M Buy
10,929
+623
+6% +$82.1K 0.09% 86
2026
Q1
$1.44M Sell
10,306
-209
-2% -$29.3K 0.11% 79
2025
Q4
$1.29M Buy
10,515
+52
+0.5% +$6.32K 0.1% 82
2025
Q3
$1.16M Buy
10,463
+64
+0.6% +$7.28K 0.1% 69
2025
Q2
$1.15M Buy
10,399
+35
+0.3% +$3.73K 0.11% 64
2025
Q1
$1.16M Sell
10,364
-6
-0.1% -$619 0.09% 77
2024
Q4
$958K Sell
10,370
-416
-4% -$37.5K 0.09% 79
2024
Q3
$904K Sell
10,786
-2,877
-21% -$220K 0.09% 79
2024
Q2
$937K Buy
13,663
+596
+5% +$39.8K 0.1% 73
2024
Q1
$957K Sell
13,067
-135
-1% -$10.4K 0.11% 73
2023
Q4
$1.07M Buy
13,202
+82
+0.6% +$6.38K 0.13% 67
2023
Q3
$983K Sell
13,120
-356
-3% -$27.4K 0.14% 69
2023
Q2
$1.04M Sell
13,476
-1,571
-10% -$125K 0.14% 57
2023
Q1
$1.25M Buy
15,047
+386
+3% +$32K 0.18% 50
2022
Q4
$1.26M Buy
14,661
+1,636
+13% +$130K 0.2% 50
2022
Q3
$804K Buy
13,025
+4,260
+49% +$269K 0.15% 59
2022
Q2
$542K Buy
+8,765
New +$543K 0.09% 68
2022
Q1
Sell
-6,737
Closed -$489K 148
2021
Q4
$489K Buy
6,737
+1,828
+37% +$126K 0.07% 85
2021
Q3
$343K Buy
4,909
+817
+20% +$57.4K 0.06% 101
2021
Q2
$283K Buy
+4,092
New +$273K 0.05% 109

Other funds holding GILD

N.E.W. Advisory Services's GILD Position: Q2 2026 in Review

N.E.W. Advisory Services increased its Gilead Sciences (GILD) stake by 6% in Q2 2026, buying an estimated $82.1K and bringing the position to 10,929 shares worth $1.38M. The position accounts for 0.09% of the portfolio, ranked #86.

N.E.W. Advisory Services first reported a position in GILD in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.44M in Q1 2026. 1,573 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • N.E.W. Advisory Services held 10,929 shares of Gilead Sciences worth $1.38M as of Q2 2026.
  • N.E.W. Advisory Services bought 623 Gilead Sciences shares in Q2 2026, an estimated $82.1K.
  • Gilead Sciences made up 0.09% of N.E.W. Advisory Services's portfolio in Q2 2026, its #86 holding.
  • N.E.W. Advisory Services first reported a position in Gilead Sciences in Q2 2021 and has held it in 20 quarters since.
  • N.E.W. Advisory Services's Gilead Sciences position peaked at $1.44M in Q1 2026.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.